Health Trials

Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers

ConditionsGastrostomyGastricGastroEsophageal Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center

About this trial

To compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG.

Eligibility criteria

Qualifiers

Able to speak and read English, Spanish, Japanese or Korean

Participants with a biopsy-confirmed diagnosis of non-metastatic gastric or GEJ adenocarcinoma, who are scheduled to undergo MIPG or MITG for curative-intention

Age ≥ 18

Participants with known malabsorption syndromes or a lack of physical integrity of the upper gastrointestinal tract

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Standard of Care
  • Control Group

Treatment groups

20 Participants
are divided into 2 treatment groups

Locations

4
Japan
Keio University School of Medicine1600016, Tokyo Japan
South Korea
Yonsei University College of Medicine03722, Soeul South Korea
United States
Mayo Clinic in Rochester55905, RochesterMinnesota, United States
M D Anderson Cancer Center77030, HoustonTexas, United States

Sponsors and collaborators

M.D. Anderson Cancer Center

Lead sponsor

Source ClinicalTrials.gov